Research Article

Topological Descriptors and QSPR Modelling of HIV/AIDS Disease Treatment Drugs

Table 18

Comparison of Molar refractivity.

Name of drugMolar refractivity of drugMolar refractivity computed from regression model
ABCRSGAM1M2FHHM

Vidaza51.1 ± 5.0 cm3129.4744131.5672128.2195127.0814131.417136.69142.11129.493139.18
Lamivudine102.61107.308104.8882102.925499.28197.148103.71108.2263100.182
Darunavir351.8619353.3656349.7263345.71353.691357.66365.79349.1477362.101
Disovey116.4869119.1488116.4133114.7652115.349115.756122.91118.5559119.154
Maraviroc422.3142411.1256422.2501431.4467436.709450.7433.95415.0744441.678
Tenofovir342.5 ± 3.0 cm3368.0517375.0256369.4033358.7746351.013332.074343.71371.6296338.386
Tipranavir384.6 ± 3.0 cm3478.0001472.0624478.7512476.3564495.625508.85522.27470.064516.512
Atazanavir587.2368592.7808583.8826579.5126575.965560.022566.43588.5499563.942
Lopinavir512.7 ± 3.0 cm3511.9809526.3568525.6949527.1179495.625485.59453.15535.687468.028
Abacavir338.4 ± 3.0 cm3199.9267195.1032203.2732212.0696211.757225.078211.23201.496217.176
Etravirine339.3 ± 3.0 cm3259.8824255.4624255.8389257.7958259.961259.968259.23254.0551259.336
Nelfinavir429.7 ± 3.0 cm3469.1046456.756457.9498462.6113479.557485.59497.31453.0507492.27
Toreforant323 ± 3.0 cm3376.7693380.224377.2741375.922367.081357.66357.15380.7439357.358